Australian medical cannabis company Bod Science Limited (ASX:BOD) has provided preliminary top-line results from its phase IIB clinical trial of a potential Schedule 3...

A New Zealand company looking to cultivate medical cannabis has found plenty of financial support through a crowdfunding campaign.Puro kicked off its campaign on...

MPX International Corporation says its Australian subsidiary has been awarded a Cannabis Manufacture Licence by the nation's Office of Drug Control.The licence was granted...

Australia's MGC Pharmaceuticals has announced a definitive supply agreement that will see its first epilepsy medicine in the hands of Australian patients.The company has...